I have been a patient of Nurse Gabs for several years now
A prospective clinical trial conducted in India reported a significant decrease in LFC, but liver enzymes, liver stiffness, and pancreatic fat did not show statistically significant differences after 24 weeks of treatment with dulaglutide 1.5 mg in patients with MASLD and T2DM
Each independent comparison was treated as a separate data point
*Correspondence: Daria Skuratovskaia, [email protected] This article was submitted to Computational Genomics, a section of the journal Frontiers in Genetics Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
For people whose NAD+ levels are already depleted common in those with metabolic dysfunction supplementing to optimal levels may help address that energy gap
Understanding which is which helps you respond appropriately